RealTime Laboratories Released New Mycotoxin Test Panel
The expanded diagnostic tool aims to help patients and providers identify mold exposure markers.
Updated on Sept. 22, 2026 in Allergies
Live Poll
Do you trust that new medical diagnostic tests reliably improve patient health outcomes?
RealTime Laboratories has launched a new urinary mycotoxin test panel featuring 31 total markers. The updated panel is designed to provide practitioners and patients with a more comprehensive overview of potential mold exposure.
Why it matters
Understanding mold exposure remains a complex challenge for many patients, and this expanded testing aims to offer clinicians a broader data set for identifying specific mycotoxin signatures in the body.
The new testing panel includes 31 mycotoxin markers, reflecting an addition of 16 mycotoxins compared to previous versions. It is currently unknown how these additional markers translate to improved clinical outcomes for patients presenting with mold-related concerns.
The players
RealTime Laboratories
A laboratory company focused on diagnostic testing for environmental mold and mycotoxin exposure.
The details
The panel utilizes liquid chromatography-tandem mass spectrometry to identify the presence of specific fungal metabolites in urine samples. Additionally, the laboratory employs proprietary hydrolysis processing technology, which helps to isolate and detect a more comprehensive range of mycotoxin compounds during the analysis process.
Timeline
September 22, 2026: RealTime Laboratories launched the new mycotoxin test panel.
Health Landscape
This launch represents an expansion in the available diagnostic technology for environmental health monitoring in the United States. It sits within a landscape where practitioners are increasingly looking for more granular data to assess patient concerns regarding indoor mold exposure.
If you suspect mold exposure is affecting your health, discuss whether advanced diagnostic testing is appropriate with your primary care physician. It is important to remember that such tests are tools to be interpreted in the context of your specific clinical history and symptoms.
The takeaway
Expanded diagnostic panels are one way clinicians attempt to gain a clearer picture of environmental exposures. Always consult your healthcare provider to determine if specific lab testing for mycotoxins is relevant to your health concerns and personal medical history.
Further reading
For more information on managing environmental reactions, visit our Allergies section.
Live Poll
Do you trust that new medical diagnostic tests reliably improve patient health outcomes?
